Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for ACADIA Pharmaceuticals Inc. (ACAD)

« Back to company index

ACAD Chatter Timeline

Stock Ticker for ACAD

Most Active Tweeters for ACAD

UserTweets
@bulletin_en 15
@mmahotstuff1 10
@reurope_stock 9
@BlogYomi 8
@1MinuteStock 6

Recent Tweets for ACAD

ForTheRecord01 @ForTheRecord01
$acad Where has @AF_biotech been for the last 7 years? Nuplazid (pimavanserin), a 5HT2A inverse agonist, has been… https://t.co/tTZEG4tfTk
April 19th 2019, 2:04pm
WeekHerald @WeekHerald
ACADIA Pharmaceuticals $ACAD Trading Down 8.6% https://t.co/YxTTDztsol
April 19th 2019, 1:04pm
OlympiaReport @OlympiaReport
ACADIA Pharmaceuticals $ACAD Stock Price Down 8.6% https://t.co/N1elhilWY7
April 19th 2019, 1:04pm
ConsumerFeed @ConsumerFeed
BidaskClub Downgrades ACADIA Pharmaceuticals $ACAD to Hold https://t.co/3ox28b7re4
April 19th 2019, 12:04pm
SwingTradeBot @SwingTradeBot
Recent $ACAD technical alerts: Hammer Candlestick plus 13 more alerts... https://t.co/bE2LrE6Q53
April 19th 2019, 9:04am
BlogYomi @BlogYomi
Kezar Life Sciences Inc. $ACAD Comparing side by side https://t.co/MdKxw3Q9jI
April 18th 2019, 11:04pm
AustinJamison1 @AustinJamison1
$ACAD This stock has F’d me! I’m not worried and added yesterday to my June calls @ $27
April 18th 2019, 4:04pm
AustinJamison1 @AustinJamison1
$ACAD Wow.. wave ??????? Ok, so we went down almost a dollar today to end higher?? ? Shorts got nothing but wanting to buy lower.
April 18th 2019, 4:04pm
AustinJamison1 @AustinJamison1
$ACAD This has no reason being down here. Almost priced during scandal.. This could be a fake out & great bounce post ER!!
April 18th 2019, 2:04am
AmericanBanking @AmericanBanking
Research Analysts’ Downgrades for April, 18th $ACAD, AEM, AGIO, AKBA, ALBO, ALGN, ATNX, ATRA, ATTO, BFST https://t.co/C9szSVUYPU #stocks
April 18th 2019, 1:04am
bbnsnews @bbnsnews
ACADIA Pharmaceuticals $ACAD Lowered to “Hold” at BidaskClub https://t.co/UiimsP2EIz
April 18th 2019, 1:04am
mmahotstuff1 @mmahotstuff1
$-0.54 EPS Expected for ACADIA Pharmaceuticals Inc. $ACAD https://t.co/4TzAV0Auir
April 17th 2019, 9:04pm
bibeypost_stock @bibeypost_stock
ACADIA Pharmaceuticals Inc. $ACAD Analysts See $-0.54 EPS https://t.co/1FEiW6HVlD
April 17th 2019, 9:04pm
reurope_stock @reurope_stock
Analysts See $-0.54 EPS for ACADIA Pharmaceuticals Inc. $ACAD https://t.co/IBpCyUiEX1
April 17th 2019, 9:04pm
bulletin_en @bulletin_en
As of May, 3 The EPS for ACADIA Pharmaceuticals Inc. $ACAD Expected At $-0.54 https://t.co/HL6Ff2qneh
April 17th 2019, 9:04pm
BlogYomi @BlogYomi
Reviewing Advaxis Inc. $ACAD's results https://t.co/NFyQ3ZWfis
April 17th 2019, 3:04pm
eskay1954 @eskay1954
$ACAD Those 2 investigations are hanging over ACAD!!
April 17th 2019, 2:04pm
1MinuteStock @1MinuteStock
Explore #fundamental numbers and pros and cons for $ACAD https://t.co/ADo8IjwrYZ
April 17th 2019, 2:04pm
tradingbotnyse @tradingbotnyse
Stocks with greater movement, last 15 minutes $BHVN +/- 1.1% Biohaven Pharmaceutical Holdin.. $ACAD +/- 0.95% ACAD… https://t.co/f3nFGfxNTw
April 17th 2019, 1:04pm
MarketChmln @MarketChmln
$ACAD share price decreases -7.6%. See recent news release. https://t.co/nx1yUOlkcG
April 17th 2019, 1:04pm
bulletin_en @bulletin_en
Baker Bros Advisors LP Increased Acadia Pharmaceuticals INC $ACAD Stake by $180.40 Million https://t.co/QPPcYltVLl
April 17th 2019, 1:04pm
bulletin_en @bulletin_en
Summary of ACADIA Pharmaceuticals Inc. $ACAD Ratings https://t.co/W1RuOgcgMY
April 17th 2019, 1:04pm
Allstocknews @Allstocknews
$ACAD ACADIA Pharmaceuticals to Announce First Quarter 2019 Financial Results on May 1, 2019 From our Stock News Alerts App
April 17th 2019, 9:04am
bulletin_en @bulletin_en
First Midwest Bank Trust Division Boosted Its Stake in Acadia Pharmaceuticals $ACAD as Market Valuation Rose; Aleth… https://t.co/QtJUFBvcwZ
April 17th 2019, 5:04am
mmahotstuff1 @mmahotstuff1
Analysts See $-0.54 EPS for ACADIA Pharmaceuticals Inc. $ACAD https://t.co/8XoeL01Qot
April 16th 2019, 8:04pm
reurope_stock @reurope_stock
EPS for ACADIA Pharmaceuticals Inc. $ACAD Expected At $-0.54 https://t.co/2YT8EaWHKL
April 16th 2019, 8:04pm
Marko_Sivec @Marko_Sivec
$ACAD It's about our own that we love...#NUPLAZID #PIMAVANSERIN #MEDICAL2019 https://t.co/KjCg3XmLkL
April 16th 2019, 7:04pm
AustinJamison1 @AustinJamison1
$ACAD Earnings should be good.. back to mid 30s young 40s soon! Baker Broz are loaded & could sell anytime. Staying in with Calls!
April 16th 2019, 1:04pm
AustinJamison1 @AustinJamison1
$ACAD I’ve been in this thru good, bad & ugly! The bad news is behind them. More commercials & new goals for $AC... https://t.co/PhSZ2vy9wb
April 16th 2019, 12:04pm
thefinreviewer @thefinreviewer
First Midwest Bank Trust Division Boosted Its Acadia Pharmaceuticals $ACAD Stake by $1.61 Million as Shares Rose; C… https://t.co/gksBkpnJr4
April 16th 2019, 11:04am
ForTheRecord01 @ForTheRecord01
$acad If the brief history below were a report card, Nuplazid would surely make the FDA's honor roll: https://t.co/mvtxMNzRgX
April 16th 2019, 10:04am
ForTheRecord01 @ForTheRecord01
$acad How many mid-cap biotech stocks can boast this level of conviction from Wall Street's best & brightest? https://t.co/oUVwuO6qX9
April 16th 2019, 10:04am
AlmightyZeezA @AlmightyZeezA
RT @SolarMelt: $ACAD Dug up the P2 data supporting ENHANCE, the ongoing P3 trial of Pimavanserin in patients with inadequate response to st…
April 16th 2019, 12:04am
SolarMelt @SolarMelt
$ACAD Been working on a write up, but just too much going on around here at present to get'er done right.
April 15th 2019, 11:04pm
SolarMelt @SolarMelt
$ACAD Dug up the P2 data supporting ENHANCE, the ongoing P3 trial of Pimavanserin in patients with inadequate respo… https://t.co/aS9aOfRr76
April 15th 2019, 11:04pm
bulletin_en @bulletin_en
As of May, 3 ACADIA Pharmaceuticals Inc. $ACAD EPS Estimated At $-0.54 https://t.co/tAUp1GQLyn
April 15th 2019, 8:04pm
mmahotstuff1 @mmahotstuff1
EPS for ACADIA Pharmaceuticals Inc. $ACAD Expected At $-0.54 https://t.co/RAVd674O8Y
April 15th 2019, 8:04pm
reurope_stock @reurope_stock
Baker Bros Advisors LP Upped Its Acadia Pharmaceuticals INC $ACAD Stake by $180.40 Million https://t.co/v7rp55Fqtm
April 15th 2019, 8:04am
UlmHi @UlmHi
Bangor Savings Bank Has Cut At&T $T Stake as Market Value Declined; As Acadia Pharmaceuticals $ACAD Market Valuatio… https://t.co/DNVQVdZ0Ao
April 15th 2019, 6:04am
mmahotstuff1 @mmahotstuff1
ACADIA Pharmaceuticals Inc. $ACAD Analysts See $-0.54 EPS https://t.co/g4R2epUIam
April 14th 2019, 9:04pm
bibeypost_stock @bibeypost_stock
EPS for ACADIA Pharmaceuticals Inc. $ACAD Expected At $-0.54 https://t.co/kncEEKi9sg
April 14th 2019, 9:04pm
reurope_stock @reurope_stock
$-0.54 EPS Expected for ACADIA Pharmaceuticals Inc. $ACAD https://t.co/LO7FBU9TlZ
April 14th 2019, 9:04pm
bulletin_en @bulletin_en
As of May, 3 ACADIA Pharmaceuticals Inc. $ACAD Analysts See $-0.54 EPS https://t.co/Xi5Hcqj4OV
April 14th 2019, 7:04pm
bulletin_en @bulletin_en
Baker Bros Advisors LP Increased Its Stake in Acadia Pharmaceuticals INC $ACAD by $180.40 Million as Shares Rose https://t.co/XIDorzyXta
April 14th 2019, 1:04pm
reurope_stock @reurope_stock
Analysts See $-0.54 EPS for ACADIA Pharmaceuticals Inc. $ACAD https://t.co/g2uykfzJEj
April 14th 2019, 2:04am
bulletin_en @bulletin_en
EPS for ACADIA Pharmaceuticals Inc. $ACAD forecasted at $-0.54 https://t.co/1EHDXKUGqH
April 13th 2019, 10:04pm
SelfThink4 @SelfThink4
$ACAD best days are in the past. I can remember all those Buyout rumors from like 2 years ago. Baker Brothers are s… https://t.co/RxEsXcHDgK
April 13th 2019, 9:04am
AlmightyZeezA @AlmightyZeezA
RT @SolarMelt: $ACAD Nice Pipeline. Huge potential from Nuplazid (aka Pimavanserin), which is already approved in PDP. Well established saf…
April 13th 2019, 2:04am
bulletin_en @bulletin_en
Anticipated $-0.54 EPS for ACADIA Pharmaceuticals Inc. $ACAD on May, 3 https://t.co/OrPFlxTBJN
April 12th 2019, 9:04pm
Marko_Sivec @Marko_Sivec
$ACAD Plunges a lot in a few days,nothing good here...
April 12th 2019, 6:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.